Leerink Partners Raises Price Target on Imprivata (IMPR) to $16 Following 1Q Beat and Raise

May 4, 2016 7:54 AM

Leerink Partners reiterated an Outperform rating on Imprivata (NYSE: IMPR), and raised the price target to $16.00 (from $13.00), following ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found